Which drug works better for stem cell collection? study compares zarzio and granocyte

NCT ID NCT03367117

Completed Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 70 patients with myeloma or lymphoma who needed stem cell transplants. Researchers compared two drugs, Zarzio and Granocyte, used to stimulate stem cell production before collection. The goal was to see if one drug led to better stem cell grafts. Since it was a retrospective review, it provides information but cannot prove one drug is better than the other.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Zarzio and Granocyte (both are G-CSF drugs used to stimulate stem cell production)
What this could lead to: If one drug works better, it could help doctors choose the best option for stem cell collection before transplant.
What could go wrong: This is a small, retrospective study (70 patients) that only looks back at past results, so it cannot prove cause and effect. The findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGY, GRAFT, MOBILIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphoma plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGY, GRAFT, MOBILIZATION

Contacts and locations

Locations

Study site

Brest, 29200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.